🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02938507
Treatments Being Tested
This study will test the effectiveness and safety of two doses of solabegro...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00343486
Treatments Being Tested
This study will test the hypothesis that GW427353, a beta-3 adrenergic agon...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10
Trial ID
NCT00401479
Treatments Being Tested
This is a two-part study. Part 1 is designed to find the best modified rele...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-01
Trial ID
NCT00427596
Treatments Being Tested
The purpose of this study is to determine the effect of repeat doses of sol...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06
Trial ID
NCT00501267
Treatments Being Tested
This study will test the hypothesis that GW427353, a beta-3 adrenergic agon...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08
Trial ID
NCT00394186
This is a Phase 2b, multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
Velicept Investigative Site - Birmingham
Start Date
2018-02-19
Trial ID
NCT03475706
This is a Phase 2b, multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
Velicept Investigative Site - Birmingham
Start Date
2018-07-09
Trial ID
NCT03594058